Chinese english Germany Japanese Korea

(3S,5R,8R,9S,10S,13R,14S,17R)-17-(3-furyl)-10,13-dimethyl-2,3,4,5,6,7, 8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol

(3S,5R,8R,9S,10S,13R,14S,17R)-17-(3-furyl)-10,13-dimethyl-2,3,4,5,6,7, 8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol Struktur
156722-18-8
CAS-Nr.
156722-18-8
Englisch Name:
(3S,5R,8R,9S,10S,13R,14S,17R)-17-(3-furyl)-10,13-dimethyl-2,3,4,5,6,7, 8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol
Synonyma:
CS-906;PST2238;17-triol;AC1L4BGU;Rostafuroxin;CHEMBL2068971;SureCN1716210;PST 2238, >=98%;UNII-P848LCX62B;PST2238,Rostafuroxin
CBNumber:
CB21253997
Summenformel:
C23H34O4
Molgewicht:
374.51
MOL-Datei:
156722-18-8.mol
Request For Quotation

(3S,5R,8R,9S,10S,13R,14S,17R)-17-(3-furyl)-10,13-dimethyl-2,3,4,5,6,7, 8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol Eigenschaften

Siedepunkt:
451.3±45.0 °C(Predicted)
Dichte
1.226±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Store in freezer, under -20°C
Löslichkeit
insoluble in H2O; insoluble in EtOH; ≥12.05 mg/mL in DMSO
Aggregatzustand
solid
pka
14.02±0.70(Predicted)
Farbe
White to off-white

Sicherheit

(3S,5R,8R,9S,10S,13R,14S,17R)-17-(3-furyl)-10,13-dimethyl-2,3,4,5,6,7, 8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Rostafuroxin potently inhibits binding of endogenous ouabain to the Na+/K+ ATPase (IC50 = 1.7 μM) through the Src-epidermal growth factor receptor (EGFR)-dependent signaling pathway. This blocks the ouabain-dependent increase in Na+/K+ ATPase activity. In cultured renal cells where the Na+/K+ ATPase is upregulated or has increased activity, rostafuroxin normalizes mRNA levels and Na+/K+ ATPase activity. At very low doses (1 and 10 μg/kg for 5-6 weeks) in Milan-hypertensive rats, it decreased the development of hypertension. In a Phase II clinical study, rostafuroxin did not reduce blood pressure in human patients at doses of 0.05-5.0 mg/d.

Verwenden

(3β,5β,14β)-21,23-Epoxy-24-Norchola-20,22-diene-3,14,17-triol is used as a receptor blocker in the treatment of hypertension.

(3S,5R,8R,9S,10S,13R,14S,17R)-17-(3-furyl)-10,13-dimethyl-2,3,4,5,6,7, 8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(3S,5R,8R,9S,10S,13R,14S,17R)-17-(3-furyl)-10,13-dimethyl-2,3,4,5,6,7, 8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 81)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences 		+1-631-485-4226
inquiry@bocsci.com United States 19553 58
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD 		86-571-88216897,88216896 13588875226
 sales@hzclap.com CHINA 6313 58
Baoji Guokang Bio-Technology Co., Ltd. 		0917-3909592 13892490616
 gksales1@gk-bio.com China 9316 58
Zhejiang J&C Biological Technology Co.,Limited 		+1-2135480471 +1-2135480471
 sales@sarms4muscle.com China 10522 58
InvivoChem 		+1-708-310-1919 +1-13798911105
 sales@invivochem.cn United States 6393 58
LEAP CHEM CO., LTD. 		+86-852-30606658
market18@leapchem.com China 24738 58
Hangzhou MolCore BioPharmatech Co.,Ltd. 		+86-057181025280; +8617767106207
 sales@molcore.com China 49739 58
ShenZhen Trendseen Biological Technology Co.,Ltd. 		13417589054
 trendseenbio@gmail.com China 11681 58
GIHI CHEMICALS CO.,LIMITED 		+8618058761490
 info@gihichemicals.com China 50003 58
  • (3S,5R,8R,9S,10S,13R,14S,17R)-17-(3-furyl)-10,13-dimethyl-2,3,4,5,6,7, 8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol
  • Rostafuroxin
  • PST2238
  • (3β,5β,14β)-21,23-Epoxy-24-Norchola-20,22-diene-3,14,17-triol
  • Rostafuroxin (PST-2238)
  • (3beta,5beta,14beta)-21,23-Epoxy-24-norchola-20,22-diene-3,14,17-triol
  • Rostafuroxin PST2284
  • (3beta,5beta,14beta)-21,23-Epoxy-24-norchola-20,22-diene-3,14,17-triol Rostafuroxin (PST 2238)
  • Rostafuroxin (3beta,5beta,14beta)-21,23-Epoxy-24-norchola-20,22-diene-3,14,17-triol
  • PST 2238, >=98%
  • CS-906
  • 17-β-(3-furyl)-5-β-androstane-3-β, 14-β, 17-α-triol
  • 17-(3-Furyl)-5beta-androstane-3
  • 17-triol
  • AC1L4BGU
  • CHEMBL2068971
  • PST 2238; PST-2238; AC1L4BGU; SURECN1716210; UNII-P848LCX62B; 17-(3-FURYL)-5BETA-ANDROSTANE-3;14;17-TRIOL; CHEMBL2068971; 156722-18-8
  • SureCN1716210
  • UNII-P848LCX62B
  • PST2238,Rostafuroxin
  • 24-Norchola-20,22-diene-3,14,17-triol, 21,23-epoxy-, (3β,5β,14β)-
  • 24-Norchola-20,22-diene-3,14,17-triol,21,23-epoxy-, (3b,5b,14b)-
  • Rostafuroxin,ATP1A1,RSV,PST-2238,Respiratory syncytial virus,Na+/K+ ATPase,phosphorylation,inhibit,PST2238,Tyr845,Sodium potassium pump,EGFR,antihypertensive,RSV-GFP,Inhibitor,digitoxigenin,Ouabain
  • (3β,5β,14β)-21,23-Epoxy-24-Norchola-20,22-diene-3,14,17-triol
  • (3S,5R,8R,9S,10S,13S,14S,17S)-17-(Furan-3-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol
  • (1S,3aS,3bR,5aR,7S,9aS,9bS,11aS)-1-(furan-3-yl)-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthrene-1,3a,7-triol
  • 156722-18-8
  • Inhibitors
Copyright 2019 © ChemicalBook. All rights reserved